SeekingAlpha · Feb 2, 2026
KIO: Limited Growth Catalysts But Solid Income Fund
KKR Income Opportunities Fund is rated a hold, offering a 12.6% yield but lacking clear near-term catalysts. Learn more about KIO CEF here.
KI
NYSE · KIO
KKR Income Opportunities Fund
Financial Services · Asset Management - Income
$10.98
Up+$0.12 (+1.09%)
Updated Aug 25, 2026, 9:59 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 479.82M
- P/E ratio
- 64.6
- Dividend yield
- 15.55%
- 52-week range
- $10.65 – $11.46
- Volume
- 124.85K
- Avg. volume
- 339.62K
Price performance
KIO price history
1M range · 21 trading sessions · Daily adjusted prices
KIO closed at $10.98 after 21 trading sessions, up 0.46% for the selected period.
- Last close
- $10.98
- Period change
- +0.46%
- Period low
- $10.93
- Period high
- $11.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | $10.99 | $11.00 | $10.9601 | $10.98 | 124.85K |
| Aug 21, 2026 | $10.92 | $11.00 | $10.92 | $10.96 | 136.89K |
| Aug 20, 2026 | $11.00 | $11.10 | $10.90 | $10.94 | 201.17K |
| Aug 19, 2026 | $11.03 | $11.09 | $11.02 | $11.03 | 113.91K |
| Aug 18, 2026 | $11.04 | $11.155 | $11.00 | $11.02 | 169.03K |
| Aug 17, 2026 | $11.09 | $11.11 | $11.04 | $11.08 | 216.46K |
| Aug 14, 2026 | $11.15 | $11.1859 | $11.11 | $11.12 | 145.91K |
| Aug 13, 2026 | $11.22 | $11.2791 | $11.20 | $11.21 | 366.16K |
| Aug 12, 2026 | $11.25 | $11.25 | $11.155 | $11.17 | 261.24K |
| Aug 11, 2026 | $11.22 | $11.2411 | $11.1675 | $11.21 | 106.78K |
| Aug 10, 2026 | $11.11 | $11.23 | $11.105 | $11.20 | 204.9K |
| Aug 7, 2026 | $11.05 | $11.16 | $11.05 | $11.15 | 189.96K |
| Aug 6, 2026 | $11.045 | $11.12 | $11.0164 | $11.02 | 179.9K |
| Aug 5, 2026 | $11.05 | $11.10 | $11.0087 | $11.05 | 149.61K |
| Aug 4, 2026 | $11.00 | $11.10 | $11.00 | $11.04 | 189.43K |
| Aug 3, 2026 | $11.00 | $11.045 | $10.97 | $11.00 | 184.29K |
| Jul 31, 2026 | $11.10 | $11.1527 | $10.995 | $11.01 | 275.45K |
| Jul 30, 2026 | $10.98 | $11.13 | $10.98 | $11.07 | 252.59K |
| Jul 29, 2026 | $11.03 | $11.03 | $10.9256 | $10.98 | 192.08K |
| Jul 28, 2026 | $10.94 | $11.05 | $10.92 | $11.03 | 209.93K |
| Jul 27, 2026 | $11.01 | $11.09 | $10.93 | $10.93 | 298.17K |
Latest KIO news
The latest Smart Investors Daily articles mentioning KIO.
Stock researchCompany · Overview
KIO research
Overview
Company profile and research snapshot.
Company profile
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
newsfilecorp.com · Dec 1, 2025
Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds
Encinitas, California--(Newsfile Corp. - December 1, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that the U.S. Patent and Trademark Office issued a new patent (US-12,472,263) on additional and novel formulations of the KIO-100 family of compounds, This patent allows for additional delivery options, expanding the potential therapeutic utility of the active pharmaceutical ingredient (API) in KIO-104. This newly issued patent specifically covers a novel formulation of the API in KIO-104.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
